InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Edwards Martin, Director. Director active across 3 companies, notably Verona Pharma plc. In total, 10 reports have been recorded. Breakdown: 2 buys · 1 sell. Total volume traded: €111k. Activity tracked since 4 May 2021. The latest transaction was disclosed on 1 August 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Edwards Martin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
157,992 sharesOrdinary SharesSEC:0001104659-25-097948:0
24,000 shares0Ordinary SharesSEC:0001104659-25-074386:0
2,376 sharesCommon StockSEC:0001415889-24-021823:0
33,736 shares@ US$1.83787.1% of flowOrdinary SharesSEC:0001104659-23-120809:0
Canonical exit: 18 Feb 2024 (T+90)
2,376 shares@ US$20.54100.0% of flowCommon StockSEC:0001209191-23-055428:0
Canonical exit: 11 Feb 2024 (T+90)
6,116 sharesClass A common stockSEC:0000899243-23-019533:0
133 shares@ US$93.6144.5% of flowClass A common stockSEC:0001209191-23-035769:0
359 shares@ US$34.7680.4% of flowClass A common stockSEC:0001209191-22-035381:0
59 shares@ US$27.329.8% of flowClass A common stockSEC:0001209191-22-001623:0
12,024 shares@ US$0.839712.9% of flowOrdinary SharesSEC:0001104659-21-061805:0
10 of 10 declarations
About Edwards Martin
Martin Edwards is a Director at Verona Pharma plc and Reata Pharmaceuticals Inc. He participates in the governance of these companies, bringing his expertise in biopharmaceuticals and drug development. His role is essential for guiding strategic decisions and supporting the growth of the companies.
